Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verlinde

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1Zhongsheng Zhang, Kayode K Ojo, Steven M Johnson, et al.
Trials|January 11, 2013
Improving the application of a practice guideline for the assessment and treatment of suicidal behavior by training the full staff of psychiatric departments via an e-learning supported Train-the-Trainer program: study protocol for a randomized controlled trialDerek P de Beurs, Marieke H de Groot, Jos de Keijser, et al.
Journal of Biomolecular Screening|August 29, 2014
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screeningLaura Pedró-Rosa, Frederick S Buckner, Ranae M Ranade, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapyKayode K Ojo, J Robert Gillespie, Aaron J Riechers, et al.
Molecular Microbiology|March 4, 2008
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studiesTracy L Arakaki, Frederick S Buckner, J Robert Gillespie, et al.
ACS Infectious Diseases|September 15, 2016
5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase InhibitorsZhongsheng Zhang, Cho Yeow Koh, Ranae M Ranade, et al.
Epilepsia|April 25, 2009
Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsyW Saskia van der Hel, Suzanne A M W Verlinde, Dimphna H M Meijer, et al.
Journal of Molecular Biology|July 8, 2008
Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivityEric T Larson, Wei Deng, Brian E Krumm, et al.
Plos Neglected Tropical Diseases|April 19, 2014
Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sicknessCho Yeow Koh, Jessica E Kim, Allan B Wetzel, et al.
Analytical and Bioanalytical Chemistry|July 14, 2011
Screening a fragment cocktail library using ultrafiltrationSayaka Shibata, Zhongsheng Zhang, Konstantin V Korotkov, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1Zhongsheng Zhang, Kayode K Ojo, Steven M Johnson, et al.
Trials|January 11, 2013
Improving the application of a practice guideline for the assessment and treatment of suicidal behavior by training the full staff of psychiatric departments via an e-learning supported Train-the-Trainer program: study protocol for a randomized controlled trialDerek P de Beurs, Marieke H de Groot, Jos de Keijser, et al.
Journal of Biomolecular Screening|August 29, 2014
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screeningLaura Pedró-Rosa, Frederick S Buckner, Ranae M Ranade, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapyKayode K Ojo, J Robert Gillespie, Aaron J Riechers, et al.
Molecular Microbiology|March 4, 2008
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studiesTracy L Arakaki, Frederick S Buckner, J Robert Gillespie, et al.
ACS Infectious Diseases|September 15, 2016
5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase InhibitorsZhongsheng Zhang, Cho Yeow Koh, Ranae M Ranade, et al.
Epilepsia|April 25, 2009
Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsyW Saskia van der Hel, Suzanne A M W Verlinde, Dimphna H M Meijer, et al.
Journal of Molecular Biology|July 8, 2008
Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivityEric T Larson, Wei Deng, Brian E Krumm, et al.
Plos Neglected Tropical Diseases|April 19, 2014
Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sicknessCho Yeow Koh, Jessica E Kim, Allan B Wetzel, et al.
Analytical and Bioanalytical Chemistry|July 14, 2011
Screening a fragment cocktail library using ultrafiltrationSayaka Shibata, Zhongsheng Zhang, Konstantin V Korotkov, et al.
Pageof 23